signetbio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.signetbio.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change | ||
Meta Tags
| Title | HOME | |
| Description | top of page HOME RESEARCH Diease Focus PROTAC Synthetic Lethality ABOUT US CONTACT Developing Cancer Targeted Therapies Based on Novel Disease Models Sign |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 185.230.63.171 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
signetbio.com Valuation
|
US$1,458,471
Last updated: 2023-05-18 18:52:02
signetbio.com has Semrush global rank of 7,257,123. signetbio.com has an estimated worth of US$ 1,458,471, based on its estimated Ads revenue. signetbio.com receives approximately 168,286 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, signetbio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,458,471 |
| Daily Ads Revenue | US$1,347 |
| Monthly Ads Revenue | US$40,389 |
| Yearly Ads Revenue | US$484,662 |
| Daily Unique Visitors | 11,220 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| signetbio.com. | A | 3600 | IP: 185.230.63.171 |
| signetbio.com. | A | 3600 | IP: 185.230.63.186 |
| signetbio.com. | A | 3600 | IP: 185.230.63.107 |
| signetbio.com. | NS | 86400 | NS Record: ns12.wixdns.net. |
| signetbio.com. | NS | 86400 | NS Record: ns13.wixdns.net. |
| signetbio.com. | MX | 3600 | MX Record: 40 alt3.aspmx.l.google.com. |
| signetbio.com. | MX | 3600 | MX Record: 10 aspmx.l.google.com. |
| signetbio.com. | MX | 3600 | MX Record: 20 alt1.aspmx.l.google.com. |
| signetbio.com. | MX | 3600 | MX Record: 50 alt4.aspmx.l.google.com. |
| signetbio.com. | MX | 3600 | MX Record: 30 alt2.aspmx.l.google.com. |
| signetbio.com. | TXT | 3600 | TXT Record: google-site-verification=wZ3SG8NHlP-zHbJQik6AeuaLbxYYbSpnGrlTSqIWAS8 |
HtmlToTextCheckTime:2023-05-18 18:52:02
| top of page HOME RESEARCH Diease Focus PROTAC Synthetic Lethality ABOUT US CONTACT Developing Cancer Targeted Therapies Based on Novel Disease Models Signet Therapeutics is developing new medicines to improve the lives of patients diagnosed with cancer, especially those cancers which are insensitive to chemotherapy and radiotherapy. Signet is focusing on developing new small molecule inhibitors and degraders (PROTAC) based on the novel unique disease models we have developed. Signet is leveraging experts in AI-powered drug discovery and patient-orientated disease models to revolutionize traditional drug discovery By strategically collaborating with ,we bring together the expertise of AI-powered drug discovery platform to design and develop the compounds, and novel unique disease models to select and optimize the leads. By taking these advantages, we are revolutionizing the traditional drug discovery for small molecules. Xtalpi DISEASE MODELS Novel 3D Organoids Model ( Read More |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 14 Jul 2022 09:12:57 GMT Content-Length: 0 Connection: keep-alive location: https://www.signetbio.com/ strict-transport-security: max-age=3600 x-wix-request-id: 1657789973.9334531808040225987 Age: 0 Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42 X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi+P0yj8Af8/paqX0JLrR68,m0j2EEknGIVUW/liY8BLLp4sYwYx2UgZC4DZhzpOwcVGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalhIocOq/cuKFItEuzI1yLi9GXVsb52x9ufLZjpI9SEAkB8kcxqsFm+sJqO/bq6zGsg==,2UNV7KOq4oGjA5+PKsX47I1RUfM+Gm2tbtCPQhpreUgfbJaKSXYQ/lskq2jK6SGP,osV03DUdKaEVOGwoQFgPYvJgTtvLE3piSyPad6R03fY=,sQ19iEk473qMiaixh4sATm8nuTGjjwQxfjauzcM0rFI=,adCcrjWN+9jYhIHsscsS5uc3dam7V+TdZdcj2yn8SQ7ZHWuQouT4Aby03XmokXWtWIHlCalF7YnfvOr2cMPpyw== Cache-Control: no-cache X-Content-Type-Options: nosniff |
signetbio.com Whois Information
Domain Name: SIGNETBIO.COM Registry Domain ID: 2568493910_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wix.com Registrar URL: http://www.wix.com Updated Date: 2020-10-27T10:24:37Z Creation Date: 2020-10-27T10:24:36Z Registry Expiry Date: 2022-10-27T10:24:36Z Registrar: Wix.com Ltd. Registrar IANA ID: 3817 Registrar Abuse Contact Email: domain-abuse@wix.com Registrar Abuse Contact Phone: +14154291173 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS12.WIXDNS.NET Name Server: NS13.WIXDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2022-07-14T09:20:28Z <<< |